Skip to main content

Table 2 Utilization ratios of drugs in older CAD/CHF patients with and without low GFR

From: Relationship between drug application and mortality rate in Chinese older coronary artery disease/chronic heart failure patients with and without low glomerular filtration rate

DiseasesDrugsAllWithout low GFRWith low GFRP value*
CADAspirin (%)537 (51.1)355 (52.4)182 (48.9)0.287
Clopidogrel (%)622 (59.2)409 (60.3)213 (57.3)0.333
Beta-blockers (%)705 (67.1)445 (65.6)260 (69.9)0.160
CCBs (%)664 (63.2)410 (60.5)254 (68.3)0.012
Nitrates (%)871 (83.0)558 (82.3)313 (84.1)0.449
ACEI/ARBs (%)530 (50.5)346 (51.0)184 (49.5)0.626
Statins (%)693 (66.0)453 (66.8)240 (64.5)0.452
CHFBeta-blockers (%)252 (77.1)117 (73.6)135 (80.4)0.145
ACEI/ARBs (%)178 (54.4)92 (57.9)86 (51.2)0.626
Statins (%)214 (65.4)105 (66.0)109 (64.9)0.826
Digoxin (%)168 (51.4)76 (47.8)92 (54.8)0.208
  1. *Comparing utilization ratios of drugs between patients with and without low GFR
  2. Abbreviations: ACEI/ARBs Renin-angiotensin-aldosterone system inhibitors/angiotensin receptor blockers, CAD Coronary artery disease, CHF Chronic heart failure, CCBs Calcium channel blockers, GFR Glomerular filtration rate